Advanced Prostate Cancer Treated Sucessfully with Immune Boosting Drug, Ipilimimab

DRAMATIC RESULTS FOR PROSTATE CANCER SURVIVORS WITH EXPERIMENTAL IMMUNE BOOSTING DRUG, IPILIMIMAB

TWO MEN DIAGNOSED WITH ADVANCED AND INOPERABLE PROSTATE CANCER RECOVERED AFTER BEING TREATED WITH AN EXPERIMENTAL ANTIBODY DRUG, IPILIMUMAB THAT BOOSTS THE IMMUNE SYSTEM. . BOTH ARE CANCER FREE AND HAVE RETURNED TO NORMAL LIFE.. THE GOAL OF THE STUDY AT THE MAYO CLINIC IN ROCHESTER, MINNESOTA WAS TO SEE IF THEY COULD IMPROVE UPON CURRENT TREATMENT FOR ADVANCED PROSTATE CANCER AND SUBJECTS IN THE STUDY WERE PEOPLE WHO DID NOT HAVE MANY OPTIONS BECAUSE OF THE ADVANCEMENT OF THE DISEASE. THE TREATMENT PROCESS WAS AS FOLLOWS: 1) PATIENTS RECEIVED TRADITIONAL HORMONAL THERAPY TO REMOVE TESTERONE, WHICH FUELS PROSTATE CANCER. 2) RESEARCHERS INTRODUCED A SINGLE DOSE OF IPILIMUMAB. FOLLOWING HORMONAL TREATMENT BOTH PATIENTS SAW THEIR PSA DROP TO A POINT WHERE THEY WERE ELIGIBLE FOR SURGERY. WHEN THE SURGEONS MADE THEIR INCISION THEY FOUND THE CANCER HAD SHRUNK DRAMATICALLY AND HAD DIFFICULTY FINDING IT. ONE PATIENT ALSO HAD RADIATION THERAPY AFTER THE SURGERY. FURTHER RESEARCH IS PLANNED.
A SECOND

Tags: , , , ,

Comments are closed.